SEELOS THERAPEUTICS, INC.·4

Jan 5, 7:21 PM ET

Pascoe Richard W 4

4 · SEELOS THERAPEUTICS, INC. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Pascoe Richard W
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-05+50,00050,000 total
    Exercise: $0.81Exp: 2033-01-05Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]1/12th of the shares subject to the option shall vest on February 5, 2023, and 1/12th of the shares subject to the option shall vest monthly thereafter.

Documents

2 files
  • 4
    ownership.xmlPrimary
  • EX-24

    POWER OF ATTORNEY